Partitioning of platelet-derived mitochondrial DNA between microparticle (MP)-associated and MP/platelet-depleted fractions during apheresis platelet storage: Predominance of a conserved MP-associated fraction

BACKGROUND: Mitochondrial damage due to platelet lesions can cause mtDNA release. However, platelet microparticles (MPs) can also transfer mtDNA in a conserved, protected form that may not directly participate in inflammatory signaling. This study investigated storage-dependent partitioning of platelet-derived mtDNA between an MP-enriched fraction and an MP/platelet-depleted supernatant and its relationship with oxidative stress and mitochondrial lesions in apheresis platelets. METHODS: Six apheresis platelet concentrates were analyzed by flow cytometry for P-selectin expression, phosphatidylserine (PS) exposure, reactive oxygen species (ROS), MP formation, and mitochondrial membrane potential (MMP; JC-1 Red/Green-GeoMFI ratio) during storage. Platelet-derived mtDNA was quantified by real-time polymerase chain reaction (PCR) in an MP-enriched pellet and the corresponding MP/platelet-depleted supernatant. RESULTS: Unlike MMP, platelet activation markers increased during storage. Supernatant mtDNA increased during storage but remained approximately 13-fold lower than mtDNA in the corresponding MP-enriched fraction. Supernatant mtDNA levels were associated with platelet activation, oxidative stress, and MMP loss. As experimental controls, CCCP, a mitochondrial uncoupler, induced greater MMP loss than ABT-737, a BCL-2/BCL-xL inhibitor, whereas ABT-737 produced higher supernatant mtDNA levels. These responses support assay sensitivity to mitochondrial perturbation without establishing a specific cell-death or release mechanism. CONCLUSION: Microparticles represent a major particulate-associated source of platelet-derived mtDNA during storage, whereas the supernatant signal represents an operationally MP/platelet-depleted fraction with substantially lower mtDNA levels. MP-associated mtDNA may represent a biologically conserved form, whereas its accessibility and inflammatory activity may be limited. The pathophysiological significance and precise release mechanism of mtDNA in the supernatant remain to be determined.

Authors

Institutions

Publication Details

Journal
Experimental and Molecular Pathology
Published
2026-10-13
DOI
https://doi.org/10.1016/j.yexmp.2026.105084
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Partitioning of platelet-derived mitochondrial DNA between microparticle (MP)-associated and MP/platelet-depleted fractions during apheresis platelet storage: Predominance of a conserved MP-associated fraction

Mehran Ghasemzadeh, Shahram Samiee, Ehteramolsadat Hosseini, Zeinab Nazari Robati
Experimental and Molecular Pathology
Extracellular vesicles in disease
article

Partitioning of platelet-derived mitochondrial DNA between microparticle (MP)-associated and MP/platelet-depleted fractions during apheresis platelet storage: Predominance of a conserved MP-associated fraction

Mehran Ghasemzadeh, Shahram Samiee, Ehteramolsadat Hosseini, Zeinab Nazari Robati
article en

Abstract

BACKGROUND: Mitochondrial damage due to platelet lesions can cause mtDNA release. However, platelet microparticles (MPs) can also transfer mtDNA in a conserved, protected form that may not directly participate in inflammatory signaling. This study investigated storage-dependent partitioning of platelet-derived mtDNA between an MP-enriched fraction and an MP/platelet-depleted supernatant and its relationship with oxidative stress and mitochondrial lesions in apheresis platelets. METHODS: Six apheresis platelet concentrates were analyzed by flow cytometry for P-selectin expression, phosphatidylserine (PS) exposure, reactive oxygen species (ROS), MP formation, and mitochondrial membrane potential (MMP; JC-1 Red/Green-GeoMFI ratio) during storage. Platelet-derived mtDNA was quantified by real-time polymerase chain reaction (PCR) in an MP-enriched pellet and the corresponding MP/platelet-depleted supernatant. RESULTS: Unlike MMP, platelet activation markers increased during storage. Supernatant mtDNA increased during storage but remained approximately 13-fold lower than mtDNA in the corresponding MP-enriched fraction. Supernatant mtDNA levels were associated with platelet activation, oxidative stress, and MMP loss. As experimental controls, CCCP, a mitochondrial uncoupler, induced greater MMP loss than ABT-737, a BCL-2/BCL-xL inhibitor, whereas ABT-737 produced higher supernatant mtDNA levels. These responses support assay sensitivity to mitochondrial perturbation without establishing a specific cell-death or release mechanism. CONCLUSION: Microparticles represent a major particulate-associated source of platelet-derived mtDNA during storage, whereas the supernatant signal represents an operationally MP/platelet-depleted fraction with substantially lower mtDNA levels. MP-associated mtDNA may represent a biologically conserved form, whereas its accessibility and inflammatory activity may be limited. The pathophysiological significance and precise release mechanism of mtDNA in the supernatant remain to be determined.

Experimental and Molecular PathologyVol. 148
High Institute for Education and Research in Transfusion Medicine (IR)
Good health and well-being
Openalex Percentile: Top 24%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.